What is known about the passage of Roclanda's active ingredients into human breast milk?

Roclanda’s latanoprost and its metabolites may pass into human milk, while excretion of netarsudil or its metabolites is unknown; no infant effects from netarsudil are anticipated because maternal systemic exposure is expected to be negligible, but relevant clinical data are unavailable.